Rimidi joins Kinetix, NASHNet in collaboration to improve NAFLD care

Kinetix announced a partnership with Rimidi added to the ongoing collaboration with the NASH Network, or NASHNET, to improve nonalcoholic fatty liver disease and nonalcoholic steatohepatitis care delivery, according to a press release.

“The Kinetix Group, together with NASHNET, have played a significant role in informing a best practice delivery model for NASH,” Lucienne Marie Ide, MD, PhD, founder of Rimidi, said in the release. “Their experience and expertise in optimizing care processes is integral to our mission as we strive to drive efficiency and effectiveness in managing chronic diseases using innovative technology.”

The new partnership will use Rimidi’s chronic disease management platform to synergize NAFLD-specific electronic medical record workflows with those of other cardiometabolic comorbidities and create a population health-focused approach for optimal care of patients with multiple chronic diseases, according to the release.

The collaboration was designed to address major treatment gaps in NAFLD and NASH, including early patient identification, appropriate referrals, intervention methodologies and care coordination.

Reference: www.thekinetixgroup.com